Lilly launches first dog drug

Share this article:
Eli Lilly has launched its first prescription drug for pets in the US, a beef flavored chewable tablet that helps treat dogs for separation anxiety. The drug, marketed under the name Reconcile, uses the same compound as Lilly’s blockbuster antidepressant Prozac. Reconcile is designed to be used in combination with behavior management training to help dogs that have difficulty being separated from their owner or family members. “It basically calms the dog and makes it more receptive to the training that’s supposed to go along with it,” Lilly veterinarian Steve Connell, told the Associated Press. Revenue projections and pricing for Reconcile were not made available. Reconcile has one competitor on the market Clomicalm, which is made my Novartis.
Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...